PB2046: SHORT-TERM EFFICACY OF DECITABINE IN COMBINATION WITH LOW-DOSE CHEMOTHERAPY IN THE TREATMENT OF JMML: A RETROSPECTIVE STUDY
Main Authors: | Y. Cai, J. Zhang, M. Yi, W. Zhang, X. Liu, X. Zhang, Y. Wan, L. Chang, L. Zhang, X. Chen, Y. Guo, Y. Zou, Y. Chen, J. Li, Y. Zhang, W. Yang, X. Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000851016.29268.e1 |
Similar Items
-
P759: CORRELATION ANALYSIS OF DNA METHYLATION LEVEL AND CLINICAL CHARACTERISTICS IN JMML PATIENTS
by: Y. Cai, et al.
Published: (2022-06-01) -
Decitabine-based treatment strategy improved the outcome of HSCT in JMML: a retrospective cohort study
by: Zhiyong Peng, et al.
Published: (2024-08-01) -
Effect of Low-Dose Aspirin Use After Thermal Ablation in Patients with Hepatocellular Carcinoma: A Retrospective Study
by: Chen S, et al.
Published: (2024-09-01) -
The synergistic antileukemic effects of eltrombopag and decitabine in myeloid leukemia cells
by: Shi M, et al.
Published: (2019-09-01) -
Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
by: Wen M, et al.
Published: (2018-11-01)